Although research in this area is nascent, one study in neurofibromatosis type 2 (NF2) – a tumor syndrome – indicated malonylation’s involvement in lipid metabolic changes that support tumor growth (Zou et al. 2023). This evidence concerns the gene NF2 and neoplasm.